Structural and functional plasticity of the luteinizing hormone/choriogonadotrophin receptor

Human Reproduction Update

Volumn 19, Issue 5, 2013, Pages 583-602

  Troppmann, Britta ^a   Kleinau, Gunnar ^b   Krause, Gerd ^c   Gromoll, Jörg ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Leibniz Institut fur Molekulare Pharmakologie   (United Kingdom)

Author keywords

Choriogonadotrophin; Evolution; Genomic organization; Gonadotrophins; Luteinizing hormone receptor

Indexed keywords

CHORIONIC GONADOTROPIN; DIMER; FOLLITROPIN; FOLLITROPIN RECEPTOR; GLYCOPROTEIN; HORMONE RECEPTOR; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; MESSENGER RNA; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT LUTEINIZING HORMONE;

ARTICLE; CRYSTAL STRUCTURE; DRUG BIOAVAILABILITY; DRUG MECHANISM; EXON; GENE EXPRESSION; GENOME ANALYSIS; HORMONE RECEPTOR INTERACTION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INFERTILITY THERAPY; INTRON; MALE INFERTILITY; MEDLINE; MOLECULAR EVOLUTION; MOLECULAR MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGOMERIZATION; OVULATION INDUCTION; PRIMATE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECEPTOR GENE; SIGNAL TRANSDUCTION; SPERMATOGENESIS; STRUCTURAL HOMOLOGY; SYSTEMATIC REVIEW; THREE DIMENSIONAL IMAGING;

CHORIOGONADOTROPHIN; EVOLUTION; GENOMIC ORGANIZATION; GONADOTROPHINS; LUTEINIZING HORMONE RECEPTOR;

AMINO ACID SEQUENCE; ANIMALS; CHORIONIC GONADOTROPIN; EVOLUTION, MOLECULAR; EXONS; HUMANS; LUTEINIZING HORMONE; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PRIMATES; PROTEIN CONFORMATION; RECEPTORS, LH; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84883032068     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmt023     Document Type: Article

References (224)

1. Abdennebi L, Lesport AS, Remy JJ, Grebert D, Pisselet C, Monniaux D, Salesse R. Differences in splicing of mRNA encoding LH receptor in theca cells according to breeding season in ewes. Reproduction 2002;123:819-826.
2. Adams C, Henke A, Gromoll J. A novel two-promoter-one-gene system of the chorionic gonadotropin {beta} gene enables tissue-specific expression. J Mol Endocrinol 2011;47:285-298.
3. Al-Inany HG, Aboulghar M, Mansour R, Proctor M. Recombinant versus urinary human chorionic gonadotrophin for ovulation induction in assisted conception. Cochrane Database Syst Rev 2005;2:CD003719.
4. Alvarez CA, Narayan P, Huang J, Puett D. Characterization of a region of the lutropin receptor extracellular domain near transmembrane helix 1 that is important in ligand-mediated signaling. Endocrinology 1999;140:1775-1782.
5. Angelova K, Fanelli F, Puett D. A model for constitutive lutropin receptor activation based on molecular simulation and engineered mutations in transmembrane helices 6 and 7. J Biol Chem 2002;277:32202-32213.
6. Angelova K, Fanelli F, Puett D. Contributions of intracellular loops 2 and 3of the lutropin receptor in Gs coupling. Mol Endocrinol 2008;22:126-138.
7. Angelova K, de Jonge H, Granneman JC, Puett D, Bogerd J. Functional differences of invariant and highly conserved residues in the extracellular domain of the glycoprotein hormone receptors. J Biol Chem 2010;285:34813-34827.
8. Angelova K, Felline A, Lee M, Patel M, Puett D, Fanelli F. Conserved amino acids participate in the structure networks deputed to intramolecular communication in the lutropin receptor. Cell Mol Life Sci 2011;68:1227-1239.
9. Apaja PM, Tuusa JT, Pietila EM, Rajaniemi HJ, Petaja-Repo UE. Luteinizing hormone receptor ectodomain splice variant misroutes the full-length receptor into a subcompartment of the snpplasmic reticulum. Mol Biol Cell 2006;17:2243-2255.
10. Arey BJ. Allosteric modulators of glycoprotein hormone receptors: discovery and therapeutic potential. Endocrine 2008;34:1-10.
11. Arnhold IJ, Lofrano-Porto A, Latronico AC. Inactivating mutations of luteinizing hormone beta-subunit or luteinizing hormone receptor cause oligo-amenorrhea and infertility in women. Horm Res 2009;71:75-82.
12. Ascoli M, Fanelli F, SegaloffDL. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev 2002;23:141-174.
13. Atger M, Misrahi M, Sar S, Le Flem L, Dessen P, Milgrom E. Structure of the human luteinizing hormone-choriogonadotropin receptor gene: unusual promoter and 5' non-coding regions. Mol Cell Endocrinol 1995;111:113-123.
14. Atkinson MR, Townsend-Nicholson A, Nicholl JK, Sutherland GR, Schofield PR. Cloning, characterisation and chromosomal assignment of the human adenosine A3 receptor (ADORA3) gene. Neurosci Res 1997;29:73-79.
15. Bacich DJ, Rohan RM, Norman RJ, Rodgers RJ. Characterization and relative abundance of alternatively spliced luteinizing hormone receptor messenger ribonucleic acid in the ovine ovary. Endocrinology 1994;135:735-744.
16. Banerjee P, Fazleabas AT. Extragonadal actions of chorionic gonadotropin. Rev Endocr Metab Disord 2011;12:323-332.
17. Bentov Y, Kenigsberg S, Casper RF. A novel luteinizing hormone/chorionic gonadotropin receptor mutation associated with amenorrhea, low oocyte yield, and recurrent pregnancy loss. Fertil Steril 2012;97:1165-1168. Plasticity of the LHCG receptor 597
18. Benyo DF, Zeleznik AJ. Cyclic adenosine monophosphate signaling in the primate corpus luteum: maintenance of protein kinase A activity throughout the luteal phase of the menstrual cycle. Endocrinology 1997;138:3452-3458.
19. Bernard MP, Myers RV, Moyle WR. Lutropins appear to contact two independent sites in the extracellular domain of their receptors. Biochem J 1998;335(Pt 3);611-617.
20. Bhowmick N, Huang J, Puett D, Isaacs NW, Lapthorn AJ. Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling. Mol Endocrinol 1996;10:1147-1159.
21. Bhowmick N, Narayan P, Puett D. Identification of ionizable amino acid residues on the extracellular domain of the lutropin receptor involved in ligand binding. Endocrinology 1999;140:4558-4563.
22. Bogerd J. Ligand-selective determinants in gonadotropin receptors. Mol Cell Endocrinol 2007;260-262:144-152.
23. Bonomi M, Busnelli M, Persani L, Vassart G, Costagliola S. Structural differences in the hinge region of the glycoprotein hormone receptors: evidence from the sulfated tyrosine residues. Mol Endocrinol 2006;20:3351-3363.
24. BraunT, Schofield PR, Sprengel R. Amino-terminal leucine-rich repeats in gonadotropin receptors determine hormone selectivity. EMBO J 1991;10:1885-1890.
25. Bruysters M, Christin-Maitre S, Verhoef-Post M, Sultan C, Auger J, Faugeron I, Larue L, Lumbroso S, Themmen AP, Bouchard P. A new LH receptor splice mutation responsible for male hypogonadism with subnormal sperm production in the propositus, and infertility with regular cycles in an affected sister. Hum Reprod 2008a;23:1917-1923.
26. Bruysters M, Verhoef-Post M, Themmen AP. Asp330 and Tyr331 in the C-terminal cysteine-rich region of the luteinizing hormone receptor are key residues in hormone-induced receptor activation. J Biol Chem 2008b;283:25821-25828.
27. Cailleux-Bounacer A, Reznik Y, Cauliez B, Menard JF, Duparc C, Kuhn JM. Evaluation of endocrine testing of Leydig cell function using extractive and recombinant human chorionic gonadotropin and different doses of recombinant human LH in normal men. Eur J Endocrinol 2008;159:171-178.
28. Caltabiano G, Campillo M, DeLeener A, Smits G, Vassart G, Costagliola S, Pardo L. The specificity of binding of glycoprotein hormones to their receptors. Cell Mol Life Sci 2008;65:2484-2492.
29. Casarini L, Lispi M, Longobardi S, Milosa F, La Marca A, Tagliasacchi D, Pignatti E, Simoni M. LH and CG action on the same receptor results in quantitatively and qualitatively different intracellular signalling. PLoS One 2012;7:e46682.
30. Chambers AE, Nayini KP, Mills WE, Lockwood GM, Banerjee S. Circulating LH/CG receptor (LHCGR) may identify pre-treatment IVF patients at risk of OHSS and poor implantation. Reprod Biol Endocrinol 2011a;9:161.
31. Chambers AE, Stanley PF, Randeva H, Banerjee S. Microvesicle-mediated release of soluble LH/hCG receptor (LHCGR) from transfected cells and placenta explants. Reprod Biol Endocrinol 2011b;9:64.
32. Chung KY, Rasmussen SG, Liu T, Li S, DeVree BT, Chae PS, Calinski D, Kobilka BK, Woods VL Jr, Sunahara RK. Conformational changes in the G protein Gs induced by the beta2 adrenergic receptor. Nature 2011;477:611-615.
33. Cocco S, Meloni A, Marini MG, Cao A, Moi P. A missense (T577I) mutation in the luteinizing hormone receptor gene associated with familial male-limited precocious puberty. Hum Mutat 1996;7:164-166.
34. Conti M, Hsieh M, Zamah AM, Oh JS. Novel signaling mechanisms in the ovary during oocyte maturation and ovulation. Mol Cell Endocrinol 2012;356:65-73.
35. Costagliola S, Panneels V, Bonomi M, Koch J, Many MC, Smits G, Vassart G. Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. EMBO J 2002;21:504-513.
36. Coviello AD, Haring R, Wellons M, Vaidya D, Lehtimaki T, Keildson S, Lunetta KL, He C, Fornage M, Lagou V et al. A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation. PLoS Genet 2012;8:e1002805.
37. DeMars G, Fanelli F, Puett D. The extreme C-terminal region of Galphas differentially couples to the luteinizing hormone and beta2-adrenergic receptors. Mol Endocrinol 2011;25:1416-1430.
38. Dickinson RE, Stewart AJ, Myers M, Millar RP, Duncan WC. Differential expression and functional characterization of luteinizing hormone receptor splice variants in human luteal cells: implications for luteolysis. Endocrinology 2009;150: 2873-2881.
39. Diez d'Aux RC, Pearson Murphy BE. Androgens in the human fetus. J Steroid Biochem 1974;5:207-210.
40. Dos Santos S, Bardet C, Bertrand S, Escriva H, Habert D, Querat B. Distinct expression patterns of glycoprotein hormone-alpha2 and -beta5 in a basal chordate suggest independent developmental functions. Endocrinology 2009;150:3815-3822.
41. Dos Santos S, Mazan S, Venkatesh B, Cohen-Tannoudji J, Querat B. Emergence and evolution of the glycoprotein hormone and neurotrophin gene families in vertebrates. BMC Evol Biol 2011;11:332.
42. Dufau ML. The luteinizing hormone receptor. Annu Rev Physiol 1998;60:461-496. Dufau ML, Liao M, Zhang Y. Participation of signaling pathways in the derepression of luteinizing hormone receptor transcription. Mol Cell Endocrinol 2010;314:221-227.
43. Dufau ML, Liao M, Zhang Y. Participation of signaling pathways in the derepression of luteinizing hormone receptor transcription. Mol Cell Endocrinol 2010;314:221-227.
44. Dunkel L, Raivio T, Laine J, Holmberg C. Circulating luteinizing hormone receptor inhibitor(s) in boys with chronic renal failure. Kidney Int 1997;51:777-784.
45. European Recombinant LH Study Group. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J Clin Endocrinol Metab 2001;86:2607-2618.
46. Evans BA, Bowen DJ, Smith PJ, Clayton PE, Gregory JW. A new point mutation in the luteinising hormone receptor gene in familial and sporadic male limited precocious puberty: genotype does not always correlate with phenotype. J Med Genet 1996; 33:143-147.
47. Fan QR, Hendrickson WA. Assembly and structural characterization of an authentic complex between human follicle stimulating hormone and a hormone-binding ectodomain of its receptor. Mol Cell Endocrinol 2007;260-262:73-82.
48. Fanelli F. Dimerization of the lutropin receptor: insights from computational modeling. Mol Cell Endocrinol 2007;260-262:59-64.
49. Fanelli F, Verhoef-Post M, Timmerman M, Zeilemaker A, Martens JW, Themmen AP. Insight into mutation-induced activation of the luteinizing hormone receptor: molecular simulations predict the functional behavior of engineered mutants at M398. Mol Endocrinol 2004;18:1499-1508.
50. Feng X, Muller T, Mizrachi D, Fanelli F, SegaloffDL. An intracellular loop (IL2) residue confers different basal constitutive activities to the human lutropin receptor and human thyrotropin receptor through structural communication between IL2 and helix 6, via helix 3. Endocrinology 2008;149:1705-1717.
51. Fernandez LM, Puett D. Identification of amino acid residues in transmembrane helices VI and VII of the lutropin/choriogonadotropin receptor involved in signaling. Biochemistry 1996;35:3986-3993.
52. Fields MJ, Shemesh M. Extragonadal luteinizing hormone receptors in the reproductive tract of domestic animals. Biol Reprod 2004;71:1412-1418.
53. Fowler PA, Bhattacharya S, Gromoll J, Monteiro A, O'Shaughnessy PJ. Maternal smoking and developmental changes in luteinizing hormone (LH) and the LH receptor in the fetal testis. J Clin Endocrinol Metab 2009;94:4688-4695.
54. Freamat M, Sower SA. Glycoprotein hormone receptors in the sea lamprey Petromyzon marinus. Zoolog Sci 2008;25:1037-1044.
55. FreamatM, Sower SA. Functional divergence of glycoprotein hormone receptors. Integr Comp Biol 2010;50:110-123.
56. Fredriksson R, Hoglund PJ, Gloriam DE, Lagerstrom MC, Schioth HB. Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives. FEBS Lett 2003;554:381-388.
57. Galet C, Ascoli M. The differential binding affinities of the luteinizing hormone (LH)/choriogonadotropin receptor for LH and choriogonadotropin are dictated by different extracellular domain residues. Mol Endocrinol 2005;19:1263-1276.
58. Geng Y, Tsai-Morris CH, Zhang Y, Dufau ML. The human luteinizing hormone receptor gene promoter: activation by Sp1 and Sp3 and inhibitory regulation. Biochem Biophys Res Commun 1999;263:366-371.
59. Gilchrist RL, Ryu KS, Ji I, Ji TH. The luteinizing hormone/chorionic gonadotropin receptor has distinct transmembrane conductors for cAMP and inositol phosphate signals. J Biol Chem 1996;271:19283-19287.
60. Gromoll J, Partsch CJ, Simoni M, NordhoffV, Sippell WG, Nieschlag E, Saxena BB. A mutation in the first transmembrane domain of the lutropin receptor causes male precocious puberty. J Clin Endocrinol Metab 1998;83:476-480.
61. Gromoll J, Eiholzer U, Nieschlag E, Simoni M. Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab 2000;85:2281-2286.
62. Gromoll J, Schulz A, Borta H, Gudermann T, Teerds KJ, Greschniok A, Nieschlag E, Seif FJ. Homozygous mutation within the conserved Ala-Phe-Asn-Glu-Thr motif of exon 7 of the LH receptor causes male pseudohermaphroditism. Eur J Endocrinol 2002;147:597-608. 598 Troppmann et al.
63. Gromoll J, Wistuba J, Terwort N, Godmann M, Müller T, Simoni M. A new subclass of the luteinizing hormone/chorionic gonadotropin receptor lacking exon 10 messenger RNA in the New World monkey (Platyrrhini) lineage. Biol Reprod 2003;69:75-80.
64. Gromoll J, Lahrmann L, Godmann M, Müller T, Michel C, Stamm S, Simoni M. Genomic checkpoints for exon 10 usage in the luteinizing hormone receptor type 1 and type 2. Mol Endocrinol 2007;21:1984-1996.
65. Grumbach MM. The neuroendocrinology of human puberty revisited. Horm Res 2002; 57(Suppl. 2):2-14.
66. Guan R, Wu X, Feng X, Zhang M, Hebert TE, SegaloffDL. Structural determinants underlying constitutive dimerization of unoccupied human follitropin receptors. Cell Signal 2010;22:247-256.
67. Gudermann T, Nichols C, Levy FO, Birnbaumer M, Birnbaumer L. Ca2+ mobilization by the LH receptor expressed in Xenopus oocytes independent of 3',5'-cyclic adenosine monophosphate formation: evidence for parallel activation of two signaling pathways. Mol Endocrinol 1992;6:272-278.
68. Gupta C, Chapekar T, Chhabra Y, Singh P, Sinha S, Luthra K. Differential response to sustained stimulation by hCG & LH on goat ovarian granulosa cells. Indian J Med Res 2012;13:331-340.
69. Hallast P, Saarela J, Palotie A, Laan M. High divergence in primate-specific duplicated regions: human and chimpanzee chorionic gonadotropin beta genes. BMC Evol Biol 2008;8:195.
70. Han B, Wang ZQ, Xue LQ, MaJH, LiuW, Liu BL, WuJJ, PanCM, Chen X, ZhaoSX et al. Functional study of an aberrant splicing variant of the human luteinizing hormone (LH) receptor. Mol Hum Reprod 2012;18:129-135.
71. Heitman LH, Ijzerman AP. G protein-coupled receptors of the hypothalamicpituitary- gonadal axis: a case for Gnrh, LH, FSH, and GPR54 receptor ligands. Med Res Rev 2008;28:975-1011.
72. Heitman LH, Kleinau G, Brussee J, Krause G, Ijzerman AP. Determination of different putative allosteric binding pockets at the lutropin receptor by using diverse drug-like low molecular weight ligands. Mol Cell Endocrinol 2012;351:326-336.
73. Henke A, Gromoll J. New insights into the evolution of chorionic gonadotrophin. Mol Cell Endocrinol 2008;291:11-19.
74. Henke A, Luetjens CM, Simoni M, Gromoll J. Chorionic gonadotropin beta-subunit gene expression in the marmoset pituitary is controlled by steroidogenic factor 1, early growth response protein 1, and pituitary homeobox factor 1. Endocrinology 2007;148:6062-6072.
75. Herrlich A, Kuhn B, Grosse R, Schmid A, Schultz G, Gudermann T. Involvement of Gs and Gi proteins in dual coupling of the luteinizing hormone receptor to adenylyl cyclase and phospholipase C. J Biol Chem 1996;271:16764-16772.
76. Hsu SY, Nakabayashi K, Bhalla A. Evolution of glycoprotein hormone subunit genes in bilateral metazoa: identification of two novel human glycoprotein hormone subunit family genes, GPA2 and GPB5. Mol Endocrinol 2002;16:1538-1551.
77. Huhtaniemi I. Are gonadotrophins tumorigenic-a critical review of clinical and experimental data. Mol Cell Endocrinol 2010;329:56-61.
78. Huhtaniemi IT, Catt KJ. Differential binding affinities of rat testis luteinizing hormone (LH) receptors for human chorionic gonadotropin, human LH, and ovine LH. Endocrinology 1981;108:1931-1938.
79. Huhtaniemi IT, Themmen AP. Mutations in human gonadotropin and gonadotropin-receptor genes. Endocrine 2005;26:207-217.
80. Huhtaniemi IT, Korenbrot CC, Jaffe RB. HCG binding and stimulation of testosterone biosynthesis in the human fetal testis. J Clin Endocrinol Metab 1977;44:963-967.
81. Ignacak M, Hilczer M, Zarzycki J, Trzeciak WH. Substitution of M398T in the second transmembrane helix of the LH receptor in a patient with familial male-limited precocious puberty. Endocr J 2000;47:595-599.
82. Ignacak M, Starzyk J, Dziatkowiak H, Trzeciak WH. Study of the family of a patient with male-limited precocious puberty (MPP) due to T1193C transition in exon 11 of LH receptor gene. J Endocrinol Invest 2002;25:259-263.
83. Jameson L, ChinWW, Hollenberg AN, Chang AS, Habener JF. The gene encoding the beta-subunit of rat luteinizing hormone. Analysis of gene structure and evolution of nucleotide sequence. J Biol Chem 1984;259:15474-15480.
84. Jeoung M, Lee C, Ji I, Ji TH. Trans-activation, cis-activation and signal selection of gonadotropin receptors. Mol Cell Endocrinol 2007;260-262:137-143.
85. Ji I, Lee C, Song Y, Conn PM, Ji TH. Cis- and trans-activation of hormone receptors: the LH receptor. Mol Endocrinol 2002;16:1299-1308.
86. Ji I, Lee C, Jeoung M, Koo Y, Sievert GA, Ji TH. Trans-activation of mutant follicle-stimulating hormone receptors selectively generates only one of two hormone signals. Mol Endocrinol 2004;18:968-978.
87. Jiang X, Liu H, Chen X, Chen PH, Fischer D, Sriraman V, Yu HN, Arkinstall S, He X. Structure of follicle-stimulating hormone in complex with the entire ectodomain of its receptor. Proc Natl Acad Sci USA 2012;109:12491-12496.
88. Kawate N, Okuda K. Coordinated expression of splice variants for luteinizing hormone receptor messenger RNA during the development of bovine corpora lutea. Mol Reprod Dev 1998;51:66-75.
89. Kawate N, Kletter GB, Wilson BE, NetzloffML, Menon KM. Identification of constitutively activating mutation of the luteinising hormone receptor in a family with male limited gonadotrophin independent precocious puberty (testotoxicosis). J Med Genet 1995;32:553-554.
90. Kawauchi H, Sower SA. The dawn and evolution of hormones in the adenohypophysis. Gen Comp Endocrinol 2006;148:3-14.
91. Kleinau G, Krause G. Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signaling mechanisms. Endocr Rev 2009;30:133-151.
92. Kleinau G, Brehm M, Wiedemann U, Labudde D, Leser U, Krause G. Implications for molecular mechanisms of glycoprotein hormone receptors using a new sequence-structure-function analysis resource. Mol Endocrinol 2007;21:574-580.
93. Kleinau G, Jaeschke H, Worth CL, Mueller S, Gonzalez J, Paschke R, Krause G. Principles and determinants of G-protein coupling by the rhodopsin-like thyrotropin receptor. PLoS One 2010;5:e9745.
94. Kleinau G, Mueller S, Jaeschke H, Grzesik P, Neumann S, Diehl A, Paschke R, Krause G. Defining structural and functional dimensions of the extracellular thyrotropin receptor region. J Biol Chem 2011;286:22622-22631.
95. Kolena J, Sebokova E. Porcine follicular fluid containing water-soluble LH/hCG receptor. Arch Int Physiol Biochim 1986;94:261-270.
96. Kolena J, Sebokova E, Horkovics-Kovats S. LH/hCG receptor in pig follicular fluid. Endocrinol Exp 1986;20:339-348.
97. Kossack N, Simoni M, Richter-Unruh A, Themmen AP, Gromoll J. Mutations in a novel, cryptic exon of the luteinizing hormone/chorionic gonadotropin receptor gene cause male pseudohermaphroditism. PLoS Med 2008;5:e88.
98. Kossack N, Troppmann B, Richter-Unruh A, Kleinau G, Gromoll J. Aberrant transcription of the LHCGR gene caused by a mutation in exon 6A leads to Leydig cell hypoplasia type II. Mol Cell Endocrinol 2013;366:59-67.
99. Kosugi S, Van Dop C, Geffner ME, RablW, Carel JC, Chaussain JL, Mori T, Merendino JJ Jr, Shenker A. Characterization of heterogeneous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty. Hum Mol Genet 1995;4:183-188.
100. Kosugi S, Mori T, Shenker A. An anionic residue at position 564 is important for maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor. Mol Pharmacol 1998;53:894-901.
101. Kremer H, Mariman E, Otten BJ, MollGWJr, Stoelinga GB, Wit JM, Jansen M, Drop SL, Faas B, Ropers HH. Cosegregation of missensemutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Mol Genet 1993; 2:1779-1783.
102. KremerH, Kraaij R, Toledo SP, PostM, Fridman JB, HayashidaCY, vanReenM, MilgromE, RopersHH, Mariman E. Male pseudohermaphroditismdue to a homozygousmissense mutation of the luteinizing hormone receptor gene. Nat Genet 1995;9:160-164.
103. Kremer H, Martens JW, van Reen M, Verhoef-Post M, Wit JM, Otten BJ, Drop SL, Delemarre-van de Waal HA, Pombo-Arias M, De Luca F et al. A limited repertoire of mutations of the luteinizing hormone (LH) receptor gene in familial and sporadic patients with male LH-independent precocious puberty. J Clin Endocrinol Metab 1999;84:1136-1140.
104. Kreuchwig A, Kleinau G, Kreuchwig F, Worth CL, Krause G. Research resource: update and extension of a glycoprotein hormone receptors web application. Mol Endocrinol 2011;25:707-712.
105. Kudo M, Chen T, Nakabayashi K, Hsu SY, Hsueh AJ. The nematode leucine-rich repeat-containing, G protein-coupled receptor (LGR) protein homologous to vertebrate gonadotropin and thyrotropin receptors is constitutively active in mammalian cells. Mol Endocrinol 2000;14:272-284.
106. Kühn B, GudermannT. The luteinizing hormone receptor activates phospholipaseCvia preferential coupling to Gi2. Biochemistry 1999;38:12490-12498.
107. Lapthorn AJ, Harris DC, Littlejohn A, LustbaderJW, Canfield RE, Machin KJ, Morgan FJ, Isaacs NW. Crystal structure of human chorionic gonadotropin. Nature 1994; 369:455-461.
108. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007;23:2947-2948.
109. Plasticity of the LHCG receptor 599 Latronico AC, Arnhold IJ. Inactivating mutations of the human luteinizing hormone receptor in both sexes. Semin Reprod Med 2012;30:382-386.
110. Latronico AC, Anasti J, Arnhold IJ, Mendonca BB, Domenice S, Albano MC, Zachman K, Wajchenberg BL, Tsigos C. A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab 1995;80:2490-2494.
111. Latronico AC, Anasti J, Arnhold IJ, Rapaport R, Mendonca BB, Bloise W, Castro M, Tsigos C, Chrousos GP. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med 1996;334:507-512.
112. Latronico AC, Abell AN, Arnhold IJ, Liu X, Lins TS, Brito VN, Billerbeck AE, SegaloffDL, MendoncaBB. Aunique constitutively activatingmutationin thirdtransmembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty. J Clin EndocrinolMetab 1998a;83:2435-2440.
113. Latronico AC, Chai Y, Arnhold IJ, Liu X, Mendonca BB, SegaloffDL. A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. Mol Endocrinol 1998b;12:442-450.
114. Latronico AC, Shinozaki H, Guerra G Jr, Pereira MA, Lemos Marini SH, Baptista MT, Arnhold IJ, Fanelli F, Mendonca BB, SegaloffDL. Gonadotropin-independent precocious puberty due to luteinizing hormone receptor mutations in Brazilian boys: a novel constitutively activating mutation in the first transmembrane helix. J Clin Endocrinol Metab 2000;85:4799-4805.
115. Laue L, Chan WY, Hsueh AJ, Kudo M, Hsu SY, Wu SM, Blomberg L, Cutler GB Jr. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc Natl Acad Sci USA 1995a;92:1906-1910.
116. Laue L, Wu SM, Kudo M, Hsueh AJ, Cutler GB Jr, Griffin JE, Wilson JD, Brain C, Berry AC, Grant DB. A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum Mol Genet 1995b;4:1429-1433.
117. Laue LL, WuSM, Kudo M, Bourdony CJ, CutlerGBJr, Hsueh AJ, ChanWY. Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. Mol Endocrinol 1996a;10:987-997.
118. Laue L, Wu SM, Kudo M, Hsueh AJ, Cutler GB Jr, Jelly DH, Diamond FB, Chan WY. Heterogeneity of activating mutations of the human luteinizing hormone receptor in male-limited precocious puberty. Biochem Mol Med 1996b;58:192-198.
119. Lebon G, Warne T, Tate CG. Agonist-bound structures of G protein-coupled receptors. Curr Opin Struct Biol 2012;22:482-490.
120. Lee CY, Ryan RJ. The uptake of human luteinizing hormone (hLH) by slices of luteinized rat ovaries. Endocrinology 1971;89:1515-1523.
121. LeungMY, Al-Muslim O, WuSM, Aziz A, Inam S, Awadh M, Rennert OM, ChanWY. A novelmissense homozygous inactivating mutation in the fourth transmembrane helix of the luteinizing hormone receptor in leydig cell hypoplasia. Am J Med Genet A 2004; 130A:146-153.
122. Leung MY, Steinbach PJ, Bear D, Baxendale V, Fechner PY, Rennert OM, Chan WY. Biological effect of a novel mutation in the third leucine-rich repeat of human luteinizing hormone receptor. Mol Endocrinol 2006;20:2493-2503.
123. Li C, HirookaY, Habu S, Takagi J, Gotoh M, NogimoriT. Distribution of thyrostimulin in the rat: an immunohistochemical study. Endocr Regul 2004;38:131-142.
124. Liu G, Duranteau L, Carel JC, Monroe J, Doyle DA, Shenker A. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 1999;341:1731-1736.
125. Ludwig M, Doody KJ, Doody KM. Use of recombinant human chorionic gonadotropin in ovulation induction. Fertil Steril 2003;79:1051-1059.
126. Lustbader JW, WuH, Birken S, Pollak S, Gawinowicz Kolks MA, Pound AM, Austen D, HendricksonWA, Canfield RE. The expression, characterization, and crystallization of wild-type and selenomethionyl human chorionic gonadotropin. Endocrinology 1995;136:640-650.
127. Madhra M, Gay E, Fraser HM, Duncan WC. Alternative splicing of the human luteal LH receptor during luteolysis and maternal recognition of pregnancy. Mol Hum Reprod 2004;10:599-603.
128. Malassine A, Frendo JL, Evain-Brion D. A comparison of placental development and endocrine functions between the human and mouse model. Hum Reprod Update 2003;9:531-539.
129. Mao JF, Wu XY, Nie M, Lu SY, Gong FY, Dai YF. A report of familial male-limited precocious puberty caused by a germ-line heterozygous mutation (M398T) in luteinizing hormone receptor gene. Zhonghua Nei Ke Za Zhi 2010;49:1024-1027.
130. Martens JW, Verhoef-Post M, Abelin N, Ezabella M, Toledo SP, Brunner HG, Themmen AP. A homozygous mutation in the luteinizing hormone receptor causes partial Leydig cell hypoplasia: correlation between receptor activity and phenotype. Mol Endocrinol 1998;12:775-784.
131. Martens JW, Lumbroso S, Verhoef-Post M, Georget V, Richter-Unruh A, Szarras-Czapnik M, Romer TE, Brunner HG, Themmen AP, Sultan C. Mutant luteinizing hormone receptors in a compound heterozygous patient with complete Leydig cell hypoplasia: abnormal processing causes signaling deficiency. J Clin Endocrinol Metab 2002;87:2506-2513.
132. Maston GA, Ruvolo M. Chorionic gonadotropin has a recent origin within primates and an evolutionary history of selection. Mol Biol Evol 2002;19:320-335.
133. Menon KM, Menon B. Structure, function and regulation of gonadotropin receptors-a perspective. Mol Cell Endocrinol 2012;356:88-97.
134. Michel C, Gromoll J, ChandoliaR, LuetjensCM, Wistuba J, Simoni M. LHR splicing variants and gene expression in the marmoset monkey. Mol Cell Endocrinol 2007;279:9-15.
135. Min KS, Liu X, Fabritz J, Jaquette J, Abell AN, Ascoli M. Mutations that induce constitutive activation and mutations that impair signal transduction modulate the basal and/or agonist-stimulated internalization of the lutropin/choriogonadotropin receptor. J Biol Chem 1998;273:34911-34919.
136. Minegishi T, Nakamura K, Takakura Y, Miyamoto K, Hasegawa Y, Ibuki Y, Igarashi M, Minegish T, Minegishi T. Cloning and sequencing of human LH/hCG receptor cDNA. Biochem Biophys Res Commun 1990;172:1049-1054.
137. Misrahi M, Meduri G, Pissard S, Bouvattier C, Beau I, Loosfelt H, Jolivet A, Rappaport R, MilgromE, Bougneres P. Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor. J Clin Endocrinol Metab 1997; 82:2159-2165.
138. MooreS, Jaeschke H, Kleinau G, NeumannS, Costanzi S, Jiang JK, Childress J, Raaka BM, Colson A, Paschke R et al. Evaluation of small-molecule modulators of the luteinizing hormone/choriogonadotropin and thyroid stimulating hormone receptors: structure-activity relationships and selective binding patterns. J Med Chem 2006; 49:3888-3896.
139. Moyle WR, Xing Y, Lin W, Cao D, Myers RV, Kerrigan JE, Bernard MP. Model of glycoprotein hormone receptor ligand binding and signaling. J Biol Chem 2004; 279:44442-44459.
140. Muller J, Gondos B, Kosugi S, Mori T, Shenker A. Severe testotoxicosis phenotype associated with Asp578-Tyr mutation of the lutrophin/choriogonadotrophin receptor gene. J Med Genet 1998;35:340-341.
141. Müller T, Gromoll J, Simoni M. Absence of exon 10 of the human luteinizing hormone (LH) receptor impairs LH, but not human chorionic gonadotropin action. J Clin Endocrinol Metab 2003;88:2242-2249.
142. MüllerT, Simoni M, Pekel E, LuetjensCM, Chandolia R, AmatoF, Norman RJ, Gromoll J. Chorionic gonadotrophin beta subunit mRNA but not luteinising hormone beta subunit mRNA is expressed in the pituitary of the common marmoset (Callithrix jacchus). J Mol Endocrinol 2004;32:115-128.
143. Nagasaki K, KatsumataN, Ogawa Y, Kikuchi T, Uchiyama M. Novel C617Y mutation in the 7th transmembrane segment of luteinizing hormone/choriogonadotropin receptor in a Japanese boy with peripheral precocious puberty. Endocr J 2010; 57:1055-1060.
144. Nagirnaja L, Rull K, Uuskula L, Hallast P, Grigorova M, Laan M. Genomics and genetics of gonadotropin beta-subunit genes: Unique FSHB and duplicated LHB/CGB loci. Mol Cell Endocrinol 2010;329:4-16.
145. Nakabayashi K, Kudo M, Kobilka B, Hsueh AJ. Activation of the luteinizing hormone receptor following substitution of Ser-277 with selective hydrophobic residues in the ectodomain hinge region. J Biol Chem 2000;275:30264-30271.
146. Nakabayashi K, Kudo M, Hsueh AJ, Maruo T. Activation of the luteinizing hormone receptor in the extracellular domain. Mol Cell Endocrinol 2003;202:139-144.
147. Nakamura K, Yamashita S, Omori Y, Minegishi T. A splice variant of the human luteinizing hormone (LH) receptor modulates the expression of wild-type human LH receptor. Mol Endocrinol 2004;18:1461-1470.
148. NiswenderGD, Juengel JL, Silva PJ, Rollyson MK, McIntushEW. Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev 2000;80:1-29.
149. Nurwakagari P, Breit A, Hess C, Salman-Livny H, Ben-Menahem D, Gudermann T. A conformational contribution of the luteinizing hormone-receptor ectodomain to receptor activation. J Mol Endocrinol 2007;38:259-275.
150. Oba Y, Hirai T, Yoshiura Y, Kobayashi T, Nagahama Y. Fish gonadotropin and thyrotropin receptors: the evolution of glycoprotein hormone receptors in vertebrates. Comp Biochem Physiol B Biochem Mol Biol 2001;129:441-448.
151. Osuga Y, Kudo M, Kaipia A, Kobilka B, Hsueh AJ. Derivation of functional antagonists using N-terminal extracellular domain of gonadotropin and thyrotropin receptors. Mol Endocrinol 1997;11:1659-1668.
152. Pabon JE, Li X, Lei ZM, Sanfilippo JS, Yussman MA, Rao CV. Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J Clin Endocrinol Metab 1996;81:2397-2400.
153. Page RD. TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci 1996;12:357-358.
154. Pakarainen T, Ahtiainen P, Zhang FP, Rulli S, Poutanen M, Huhtaniemi I. Extragonadal LH/hCG action-not yet time to rewrite textbooks. Mol Cell Endocrinol 2007; 269:9-16.
155. Pals-Rylaarsdam R, Liu G, BrickmanW, Duranteau L, Monroe J, El-Awady MK, Gad YZ, Shenker A. Anovel doublemutation in the luteinizing hormone receptor in a kindred with familial Leydig cell hypoplasia and male pseudohermaphroditism. Endocr Res 2005;31:307-323.
156. Park JI, Semyonov J, Chang CL, Hsu SY. Conservation of the heterodimeric glycoprotein hormone subunit family proteins and the LGR signaling system from nematodes to humans. Endocrine 2005;26:267-276.
157. Pierce JG, Parsons TF. Glycoprotein hormones: structure and function. Annu Rev Biochem 1981;50:465-495.
158. Piersma D, Verhoef-Post M, Berns EM, Themmen AP. LHreceptor gene mutations and polymorphisms: an overview. Mol Cell Endocrinol 2007a;260-262:282-286.
159. Piersma D, Verhoef-Post M, Look MP, Uitterlinden AG, Pols HA, Berns EM, Themmen AP. Polymorphic variations in exon 10 of the luteinizing hormone receptor: functional consequences and associations with breast cancer. Mol Cell Endocrinol 2007b;276:63-70.
160. Puett D, Li Y, Angelova K, Demars G, Meehan TP, Fanelli F, Narayan P. Structure- function relationships of the luteinizing hormone receptor. Ann N Y Acad Sci 2005; 1061:41-54.
161. Puett D, Li Y, DeMars G, Angelova K, Fanelli F. A functional transmembrane complex: the luteinizing hormone receptor with bound ligand and G protein. Mol Cell Endocrinol 2007;260-262:126-136.
162. Qiao J, Han B, Liu BL, Chen X, RuY, Cheng KX, Chen FG, Zhao SX, Liang J, Lu YL et al. A splice site mutation combined with a novel missense mutation ofLHCGRcause male pseudohermaphroditism. Hum Mutat 2009;30:E855-65.
163. Rasmussen SG, DeVree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS, Thian FS, Chae PS, Pardon E, Calinski D et al. Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature 2011;477:549-555.
164. Richard N, Leprince C, Gruchy N, Pigny P, Andrieux J, Mittre H, Manouvrier S, Lahlou N, Weill J, Kottler ML. Identification by array-CGH of a large deletion of luteinizing hormone receptor gene combined with a missense mutation in a patient diagnosed with a 46,XY disorder of sex development and application to prenatal diagnosis. Endocr J 2011;58:769-776.
165. Richter-Unruh A, MartensJW, Verhoef-Post M, WesselsHT, KorsWA, SinneckerGH, Boehmer A, Drop SL, Toledo SP, BrunnerHGet al. Leydig cell hypoplasia: cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene. Clin Endocrinol (Oxf) 2002a;56:103-112.
166. Richter-Unruh A, Wessels HT, Menken U, Bergmann M, Schmittmann-Ohters K, Schaper J, Tappeser S, Hauffa BP. Male LH-independent sexual precocity in a 3.5-year-old boy caused by a somatic activating mutation of the LH receptor in a Leydig cell tumor. J Clin Endocrinol Metab 2002b;87:1052-1056.
167. Richter-Unruh A, Verhoef-Post M, Malak S, Homoki J, Hauffa BP, Themmen AP. Leydig cell hypoplasia: absent luteinizing hormone receptor cell surface expression caused by a novel homozygous mutation in the extracellular domain. J Clin Endocrinol Metab 2004;89:5161-5167.
168. Richter-Unruh A, Korsch E, Hiort O, Holterhus PM, Themmen AP, Wudy SA. Novel insertion frameshift mutation of the LH receptor gene: problematic clinical distinction of Leydig cell hypoplasia from enzyme defects primarily affecting testosterone biosynthesis. Eur J Endocrinol 2005;152:255-259.
169. Rivero-Muller A, Chou YY, Ji I, Lajic S, Hanyaloglu AC, Jonas K, Rahman N, Ji TH, Huhtaniemi I. Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation. Proc Natl Acad Sci USA 2010;107:2319-2324.
170. Rivkees SA. Localization and characterization of adenosine receptor expression in rat testis. Endocrinology 1994;135:2307-2313.
171. Robert C, Gagne D, Lussier JG, Bousquet D, Barnes FL, Sirard MA. Presence of LH receptor mRNA in granulosa cells as a potential marker of oocyte developmental competence and characterization of the bovine splicing isoforms. Reproduction 2003;125:437-446.
172. Rousseau-Merck MF, Misrahi M, Atger M, Loosfelt H, Milgrom E, Berger R. Localization of the human luteinizing hormone/choriogonadotropin receptor gene (LHCGR) to chromosome 2p21. Cytogenet Cell Genet 1990;54:77-79.
173. Salvi R, Pralong FP. Molecular characterization and phenotypic expression of mutations in genes for gonadotropins and their receptors in humans. Front Horm Res 2010; 39:1-12.
174. Sangkuhl K, Schulz A, Schultz G, Schoneberg T. Structural requirements for mutational lutropin/choriogonadotropin receptor activation. J Biol Chem 2002;277: 47748-47755.
175. Scammell JG, Funkhouser JD, Moyer FS, Gibson SV, Willis DL. Molecular cloning of pituitary glycoprotein alpha-subunit and follicle stimulating hormone and chorionic gonadotropin beta-subunits from New World squirrel monkey and owl monkey. Gen Comp Endocrinol 2008;155:534-541.
176. Scheerer P, Park JH, Hildebrand PW, Kim YJ, Krauss N, Choe HW, Hofmann KP, Ernst OP. Crystal structure of opsin in its G-protein-interacting conformation. Nature 2008;455:497-502.
177. Schoneberg T, Hofreiter M, Schulz A, Rompler H. Learning from the past: evolution of GPCR functions. Trends Pharmacol Sci 2007;28:117-121.
178. SchwartzTW, Frimurer TM, Holst B, Rosenkilde MM, Elling CE. Molecularmechanism of 7TM receptor activation-a global toggle switch model. Annu Rev Pharmacol Toxicol 2006;46:481-519.
179. SegaloffDL. Diseases associated with mutations of the human lutropin receptor. Prog Mol Biol Transl Sci 2009;89:97-114.
180. Sharpe RM. Pathways of endocrine disruption during male sexual differentiation and masculinization. Best Pract Res Clin Endocrinol Metab 2006;20:91-110.
181. Shenker A, Laue L, Kosugi S, Merendino JJ Jr, Minegishi T, Cutler GB Jr. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993;365:652-654.
182. Simoni M, Gromoll J, Nieschlag E. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 1997;18:739-773.
183. Sinha SK, Bhangoo A, Ten S, Gromoll J. Leydig cell hypoplasia due to inactivating luteinizing hormone/chorionic gonadotropin receptor gene mutation presenting as a 46,XY DSD. Adv Exp Med Biol 2011;707:147-148.
184. Smits G, Campillo M, Govaerts C, Janssens V, Richter C, Vassart G, Pardo L, Costagliola S. Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO J 2003;22:2692-2703.
185. Stavrou SS, Zhu YS, Cai LQ, Katz MD, Herrera C, Defillo-Ricart M, Imperato-McGinley J. A novel mutation of the human luteinizing hormone receptor in 46XY and 46XX sisters. J Clin Endocrinol Metab 1998;83:2091-2098.
186. Strotmann R, Schrock K, Boselt I, Staubert C, Russ A, Schoneberg T. Evolution of GPCR: change and continuity. Mol Cell Endocrinol 2011;331:170-178.
187. Sun SC, Hsu PJ, Wu FJ, Li SH, Lu CH, Luo CW. Thyrostimulin, but not thyroid-stimulating hormone (TSH), acts as a paracrine regulator to activate the TSH receptor in mammalian ovary. J Biol Chem 2010;285:3758-3765.
188. Talmadge K, Vamvakopoulos NC, Fiddes JC. Evolution of the genes for the beta subunits of human chorionic gonadotropin and luteinizing hormone. Nature 1984; 307:37-40.
189. Tao YX, Johnson NB, SegaloffDL. Constitutive and agonist-dependent self-association of the cell surface human lutropin receptor. J Biol Chem 2004;279:5904-5914.
190. Tepper MA, Roberts JL. Evidence for only one beta-luteinizing hormone and no beta-chorionic gonadotropin gene in the rat. Endocrinology 1984;115:385-391.
191. Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 2000;21:551-583.
192. Toledo SP, Brunner HG, Kraaij R, Post M, Dahia PL, Hayashida CY, Kremer H, Themmen AP. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. J Clin Endocrinol Metab 1996;81:3850-3854.
193. Toth P, Lukacs H, Gimes G, Sebestyen A, Pasztor N, Paulin F, Rao CV. Clinical importance of vascular LH/hCG receptors-a review. Reprod Biol 2001;1:5-11.
194. Ulloa-Aguirre A, Crepieux P, Poupon A, Maurel MC, Reiter E. Novel pathways in gonadotropin receptor signaling and biased agonism. Rev Endocr Metab Disord 2011;12:259-274.
195. Urizar E, Montanelli L, Loy T, Bonomi M, Swillens S, Gales C, Bouvier M, Smits G, Vassart G, Costagliola S. Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO J 2005;24:1954-1964.
196. Van Koppen CJ, Zaman GJ, Timmers CM, Kelder J, Mosselman S, van de Lagemaat R, Smit MJ, Hanssen RG. A signaling-selective, nanomolar potent allosteric low Plasticity of the LHCG receptor 601 molecular weight agonist for the human luteinizing hormone receptor. Naunyn Schmiedebergs Arch Pharmacol 2008;378:503-514.
197. Van Loy T, Vandersmissen HP, Van Hiel MB, Poels J, Verlinden H, Badisco L, Vassart G, Vanden Broeck J. Comparative genomics of leucine-rich repeats containing G protein-coupled receptors and their ligands. Gen Comp Endocrinol 2008;155:14-21.
198. Vassart G, Dumont JE. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev 1992;13:596-611.
199. Vassart G, Pardo L, Costagliola S. A molecular dissection of the glycoprotein hormone receptors. Trends Biochem Sci 2004;29:119-126.
200. Vischer HF, Granneman JC, Noordam MJ, Mosselman S, Bogerd J. Ligand selectivity of gonadotropin receptors. Role of the beta-strands of extracellular leucine-rich repeats 3 and 6 of the human luteinizing hormone receptor. J Biol Chem 2003; 278:15505-15513.
201. Vlaeminck-Guillem V, Ho SC, Rodien P, Vassart G, Costagliola S. Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol Endocrinol 2002;16:736-746.
202. Wang Z, Li T, Zhang W, You L, Zhao Y, Xia M, Zhao H, Chen ZJ. Variants in DENND1A and LHCGR are associated with endometrioid adenocarcinoma. Gynecol Oncol 2012;127:403-405.
203. West AP, Cooke BA. Regulation of the truncation of luteinizing hormone receptors at the plasma membrane is different in rat and mouse Leydig cells. Endocrinology 1991; 128:363-370.
204. Wu H, Lustbader JW, Liu Y, Canfield RE, Hendrickson WA. Structure of human chorionic gonadotropin at 2.6 A resolution from MAD analysis of the selenomethionyl protein. Structure 1994;2:545-558.
205. Wu SM, Jose M, Hallermeier K, Rennert OM, ChanWY. Polymorphisms in the coding exons of the human luteinizing hormone receptor gene. Mutations in brief no. 124. Online. Hum Mutat 1998;11:333-334.
206. Wu SM, Leschek EW, Brain C, Chan WY. A novel luteinizing hormone receptor mutation in a patient with familial male-limited precocious puberty: effect of the size of a critical amino acid on receptor activity. Mol Genet Metab 1999;66: 68-73.
207. Wurzel JM, Curatola LM, Gurr JA, Goldschmidt AM, Kourides IA. The luteotropic activity of rat placenta is not due to a chorionic gonadotropin. Endocrinology 1983; 113:1854-1857.
208. Yano K, Hidaka A, Saji M, Polymeropoulos MH, Okuno A, Kohn LD, Cutler GB Jr. A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases. J Clin Endocrinol Metab 1994;79:1818-1823.
209. Yano K, Saji M, Hidaka A, Moriya N, Okuno A, Kohn LD, Cutler GB Jr. A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty. J Clin Endocrinol Metab 1995;80:1162-1168.
210. Yariz KO, Walsh T, Uzak A, Spiliopoulos M, Duman D, Onalan G, King MC, Tekin M. Inherited mutation of the luteinizing hormone/choriogonadotropin receptor (LHCGR) in empty follicle syndrome. Fertil Steril 2011;96:e125-e130. Young JM, McNeilly AS. Theca: the forgotten cell of the ovarian follicle. Reproduction 2010;140:489-504.
211. Young JM, McNeilly AS. Theca: the forgotten cell of the ovarian follicle. Reproduction 2010;140:489-504.
212. Youssef MA, Al-Inany HG, Aboulghar M, Mansour R, Abou-Setta AM. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles. Cochrane Database Syst Rev 2011;4:CD003719.
213. Zeng H, Phang T, Song YS, Ji I, Ji TH. The role of the hinge region of the luteinizing hormone receptor in hormone interaction and signal generation. J Biol Chem 2001; 276:3451-3458.
214. Zhang Y, Dufau ML. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex. J Biol Chem 2002; 277:33431-33438.
215. Zhang Y, Dufau ML. Dual mechanisms of regulation of transcription of luteinizing hormone receptor gene by nuclear orphan receptors and histone deacetylase complexes. J Steroid Biochem Mol Biol 2003;85:401-414.
216. Zhang FP, Hamalainen T, Kaipia A, Pakarinen P, Huhtaniemi I. Ontogeny of luteinizing hormone receptor gene expression in the rat testis. Endocrinology 1994; 134:2206-2213.
217. Zhang R, Buczko E, Dufau ML. Requirement of cysteine residues in exons 1-6 of the extracellular domain of the luteinizing hormone receptor for gonadotropin binding. J Biol Chem 1996;271:5755-5760.
218. Zhang FP, Rannikko AS, Manna PR, Fraser HM, Huhtaniemi IT. Cloning and functional expression of the luteinizing hormone receptor complementary deoxyribonucleic acid from the marmoset monkey testis: absence of sequences encoding exon 10 in other species. Endocrinology 1997;138:2481-2490.
219. Zhang M, Shi H, SegaloffDL, Van Voorhis BJ. Expression and localization of luteinizing hormone receptor in the female mouse reproductive tract. Biol Reprod 2001; 64:179-187.
220. Zhang Y, Fatima N, Dufau ML. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Mol Cell Biol 2005;25:7929-7939.
221. Zhang M, Feng X, Guan R, Hebert TE, SegaloffDL. A cell surface inactive mutant of the human lutropin receptor (hLHR) attenuates signaling of wild-type or constitutively active receptors via heterodimerization. Cell Signal 2009;21:1663-1671.
222. Zhang M, Guan R, SegaloffDL. Revisiting and Questioning Functional Rescue between Dimerized LH Receptor Mutants. Mol Endocrinol 2012;26:655-668.
223. Ziecik AJ, Derecka-Reszka K, Rzucidlo SJ. Extragonadal gonadotropin receptors, their distribution and function. J Physiol Pharmacol 1992;43:33-49.
224. Ziecik AJ, Kaczmarek MM, Blitek A, Kowalczyk AE, Li X, Rahman NA. Novel biological and possible applicable roles of LH/hCG receptor. Mol Cell Endocrinol 2007; 269:51-60.